Skip to main content
NCBI home page
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 1989 Jan;71(1):44–47.

The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss.

M C Foster 1, P W Wenham 1, P A Rowe 1, R P Burden 1, A G Morgan 1, R E Cotton 1, R W Blamey 1
PMCID: PMC2498874  PMID: 2647024

Abstract

The results of 279 renal transplants performed in a single centre between 1974 and 1986 are reviewed. Improvements in the management of acute rejection and a reduction in mortality have resulted in an improvement in 1-year actuarial graft survival rates from 44% for transplants performed before 1980 to 68% for those performed after 1983. After the second year post-transplant there has been a steady rate of graft failure (6% per annum), mainly due to chronic rejection. In total 52 grafts have developed chronic rejection (19% of the total and 30% of those at risk at 6 months). Chronic rejection is assuming greater relative importance as a cause of graft loss as early results improve.

Full text

PDF
44

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abele R., Novick A. C., Braun W. E., Steinmuller D., Buszta C., Greenstreet R., Hinton J. Long-term results of renal transplantation in recipients with a functioning graft for 2 years. Transplantation. 1982 Nov;34(5):264–267. doi: 10.1097/00007890-198211000-00005. [DOI] [PubMed] [Google Scholar]
  2. Bradley B. A., Selwood N. H., Klouda P. T., Gilks W. R., Gore S. M., Ray T. R., Moras D., Riggulsford M. Kidney transplants in the United Kingdom. Clin Transpl. 1986:47–51. [PubMed] [Google Scholar]
  3. Calne R. Y., Wood A. J. Cyclosporin in cadaveric renal transplantation: 3-year follow-up of a European multicentre trial. Lancet. 1985 Sep 7;2(8454):549–549. doi: 10.1016/s0140-6736(85)90477-5. [DOI] [PubMed] [Google Scholar]
  4. Canafax D. M., Simmons R. L., Sutherland D. E., Fryd D. S., Strand M. H., Ascher N. L., Payne W. D., Najarian J. S. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine. Transplant Proc. 1986 Apr;18(2 Suppl 1):192–196. [PubMed] [Google Scholar]
  5. Feehally J., Harris K. P., Bennett S. E., Walls J. Is chronic renal transplant rejection a non-immunological phenomenon? Lancet. 1986 Aug 30;2(8505):486–488. doi: 10.1016/s0140-6736(86)90359-4. [DOI] [PubMed] [Google Scholar]
  6. Hendrick A., Wallin J. D., O'Neill W. M., Jr Plasma exchange in chronic renal allograft rejection. Transplantation. 1984 Mar;37(3):318–319. doi: 10.1097/00007890-198403000-00022. [DOI] [PubMed] [Google Scholar]
  7. Kincaid-Smith P. Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants. Lancet. 1969 Nov 1;2(7627):920–922. doi: 10.1016/s0140-6736(69)90587-x. [DOI] [PubMed] [Google Scholar]
  8. Kirkman R. L., Strom T. B., Weir M. R., Tilney N. L. Late mortality and morbidity in recipients of long-term renal allografts. Transplantation. 1982 Dec;34(6):347–351. doi: 10.1097/00007890-198212000-00007. [DOI] [PubMed] [Google Scholar]
  9. Leithner C., Sinzinger H., Schwarz M. Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant; prolongation of platelet survival and improvement of transplant function. Prostaglandins. 1981 Nov;22(5):783–788. doi: 10.1016/0090-6980(81)90217-3. [DOI] [PubMed] [Google Scholar]
  10. McGeown M. G., Douglas J. F., Brown W. A., Donaldson R. A., Kennedy J. A., Loughridge W. G., Mehta S., Nelson S. D., Doherty C. C., Johnstone R. Advantages of low dose steroid from the day after renal transplantation. Transplantation. 1980 Apr;29(4):287–289. doi: 10.1097/00007890-198004000-00005. [DOI] [PubMed] [Google Scholar]
  11. Opelz G., Mickey M. R., Terasaki P. I. Calculations on long-term graft and patient survival in human kidney transplantation. Transplant Proc. 1977 Mar;9(1):27–30. [PubMed] [Google Scholar]
  12. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Teraoka S., Takahashi K., Toma H., Yagisawa T., Yamaguchi Y., Sanaka T., Fuchinoue S., Honda H., Kawai T., Tanabe K. New approach to management of chronic vascular rejection with prostacyclin analogue after kidney transplantation. Transplant Proc. 1987 Feb;19(1 Pt 3):2115–2119. [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES